Treadwell v. Abbott Laboratories et al
| Cecilia Treadwell |
| Abbott Laboratories, Takeda Pharmaceuticals USA, Inc., Astrazeneca LP, Takeda Pharmaceutical Company Limited, Merck & Co., Inc., The Procter & Gamble Company, Astrazeneca Pharmaceuticals LP, Pfizer, Inc., The Procter & Gamble Distributing LLC, The Procter & Gamble Manufacturing Company, Takeda Development Center Americas, Inc. and Takeda Pharmaceuticals America, Inc. |
| 1:2019cv04462 |
| July 2, 2019 |
| US District Court for the Northern District of Illinois |
| Edmond E Chang |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. § 1332 |
| Both |
Docket Report
RSS Track this Docket
This docket was last retrieved on August 12, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 21 MINUTE entry before the Honorable Edmond E. Chang:In light of the MDL transfer, all motions are terminated and the status hearing of 08/13/2019 is vacated. Emailed notice (slb, ) |
| ELECTRONIC Acknowledgement of case transferred to the District of New Jersey [LIVE] as case 2:19-cv-15694, filed 07/22/2019. (jjr, ) |
| Filing 20 MINUTE entry before the Honorable Edmond E. Chang: On Defendants' motion #13 to stay, Plaintiff's response is due by 08/01/2019 either (1) as part of a motion to remand, R. 12; or (2) if no remand motion is filed, as a stand-alone response to the stay motion. Defendants' reply, if any, is due by 08/12/2019 either (1) as part of the response to the remand motion; or (2) as a stand-alone reply. The motion #13 hearing is reset to 08/13/2019 at 10 a.m., and in in the interim all deadlines are stayed. Emailed notice (slb, ) |
| Filing 19 TRANSFERRED to the District of New Jersey the electronic record. (kp, ) |
| Filing 18 CONDITIONAL TRANSFER ORDER from MDL Panel transferring case to New Jersey. (kp, ) |
| ***Civil Case Terminated. (kp, ) |
| Filing 17 ATTORNEY Appearance for Defendant The Procter & Gamble Company by Kerry Carson Green (Green, Kerry) |
| Filing 16 ATTORNEY Appearance for Defendant The Procter & Gamble Company by Jeffrey Daniel Geoppinger (Geoppinger, Jeffrey) |
| Filing 15 ATTORNEY Appearance for Defendant Pfizer, Inc. by Amy Michelle Rubenstein (Rubenstein, Amy) |
| Filing 14 NOTICE of Motion by Isaac J. Colunga for presentment of motion to stay #13 before Honorable Edmond E. Chang on 7/24/2019 at 08:30 AM. (Colunga, Isaac) |
| Filing 13 MOTION by Defendants Astrazeneca LP, Astrazeneca Pharmaceuticals LP, Merck & Co., Inc. to stay (Attachments: #1 Exhibit A, #2 Exhibit B)(Maly, Heather) |
| Filing 12 MINUTE entry before the Honorable Edmond E. Chang:On review of the notice of removal and the complaint, R. 1, the Court sets the following schedule: if Plaintiff is going to challenge subject matter jurisdiction, then Plaintiff must file a motion to remand by 08/01/2019 (which is 30 days after the filing of the notice of removal). The defense response is due by 08/12/2019. The status hearing remains set for 08/13/2019. Emailed notice (slb, ) |
| Filing 11 MINUTE entry before the Honorable Edmond E. Chang: Initial status hearing set for 08/13/2019 at 10:00 a.m. The parties must file a joint initial status report with the content described in the attached status report requirements at least 3 business days before the initial status hearing. Plaintiff must still file the report even if not all Defendants have been served or have responded to requests to craft a joint report. Because the Procedures are occasionally revised, counsel must read them anew even if counsel has appeared before Judge Chang in other cases.Emailed notice (Attachments: #1 Status Report Requirements) (slb, ) |
| Filing 10 MINUTE entry before the Honorable Edmond E. Chang: Initial status hearing set for 08/13/2019 at 10:00 a.m. The parties must file a joint initial status report with the content described in the attached status report requirements at least 3 business days before the initial status hearing. Plaintiff must still file the report even if not all Defendants have been served or have responded to requests to craft a joint report. Because the Procedures are occasionally revised, counsel must read them anew even if counsel has appeared before Judge Chang in other cases.Emailed notice (Attachments: #1 Status Report Requirements) (slb, ) |
| Filing 9 ATTORNEY Appearance for Defendants Astrazeneca LP, Astrazeneca Pharmaceuticals LP, Merck & Co., Inc. by Heather Lynn Maly (Maly, Heather) |
| Filing 8 ATTORNEY Appearance for Defendants Astrazeneca LP, Astrazeneca Pharmaceuticals LP, Merck & Co., Inc. by Isaac J. Colunga (Colunga, Isaac) |
| Filing 7 E-MAILED notice of removal letter to Samuel E. Geisler (las, ) |
| Filing 6 NOTICE TO THE PARTIES - The Court is participating in the Mandatory Initial Discovery Pilot (MIDP). The key features and deadlines are set forth in this Notice which includes a link to the (MIDP) Standing Order and a Checklist for use by the parties. In cases subject to the pilot, all parties must respond to the mandatory initial discovery requests set forth in the Standing Order before initiating any further discovery in this case. Please note: The discovery obligations in the Standing Order supersede the disclosures required by Rule 26(a)(1). Any party seeking affirmative relief must serve a copy of the following documents (Notice of Mandatory Initial Discovery and the Standing Order) on each new party when the Complaint, Counterclaim, Crossclaim, or Third-Party Complaint is served. (las, ) |
| Filing 5 CIVIL Cover Sheet (Amended) (Sims, Riele)(Docket Text Modified by Clerk's Office) Modified on 7/2/2019 (pk, ). |
| Filing 4 NOTIFICATION of Affiliates pursuant to Local Rule 3.2 by Merck & Co., Inc. D/B/A Merck, Sharp & Dohme Corporation (Sims, Riele) |
| Filing 3 NOTIFICATION of Affiliates pursuant to Local Rule 3.2 by Astrazeneca LP, Astrazeneca Pharmaceuticals LP (Sims, Riele) |
| Filing 2 ATTORNEY Appearance for Defendants Astrazeneca LP, Astrazeneca Pharmaceuticals LP, Merck & Co., Inc. D/B/A Merck, Sharp & Dohme Corporation by Riele Jaalise Sims (Sims, Riele) |
| Filing 1 NOTICE of Removal from Circuit Court of Cook County, case number (2019L005998) filed by Astrazeneca LP, Astrazeneca Pharmaceuticals LP, Merck & Co., Inc. D/B/A Merck, Sharp & Dohme Corporation Filing fee $ 400, receipt number 0752-15991057. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Civil Cover Sheet Civil Cover Sheet)(Sims, Riele) |
| CASE ASSIGNED to the Honorable Edmond E. Chang. Designated as Magistrate Judge the Honorable Mary M. Rowland. Case assignment: Random assignment. (ec, ) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Illinois Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
